"La Clinique La Croix du Sud est un nouvel établissement résolument tourné vers l’avenir. Vous apprécierez sa modernité, sa fluidité et votre prise en charge par des équipes bienveillantes qui vous permettront de vous sentir dans un établissement à taille humaine. La Clinique La Croix du Sud est un établissement du groupe Ramsay Santé."

During the past decade, Clinique La Croix Du Sud conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique La Croix Du Sud" #1 sponsor was "Institut Claudius Regaud" with 2 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Centre Hospitalier Universitaire de Nīmes" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique La Croix Du Sud" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Biotronik France" with 1 trials as a collaborator, "CENTRE HOSPITALIER COMMINGES PYRENEES" with 1 trials as a collaborator, "Centre Hospitalier Ales" with 1 trials as a collaborator and "Centre Hospitalier Intercommunal de Castres" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Clinique La Croix Du Sud" are "Benign Prostatic Hyperplasia (BPH)" (1 trials), "Cancer" (1 trials), "Coronary Artery Disease" (1 trials), "Digestive Oncology" (1 trials) and "Epithelial Ovarian Cancer" (1 trials). Many other conditions were trialed in "Clinique La Croix Du Sud" in a lesser frequency.

Most popular intervention types in "Clinique La Croix Du Sud" are "Drug" (5 trials), "Device" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apalutamide" (2 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Aromatase Inhibitors" (1 trials), "Blood samples of 10 mL" (1 trials) and "Construction of a prognostic score (non-drug intervention types)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique La Croix Du Sud" are 4 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique La Croix Du Sud". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinique La Croix Du Sud, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique La Croix Du Sud, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".